Stromal biology examines how fibroblasts and endothelial cells shape tissue development, function, and pathology through interactions with parenchymal and immune cells. This meeting will focus on stromal regulation of immune-driven outcomes in homeostasis, infection, cancer, autoimmunity, and fibrosis, highlighting new tools to study these processes in vivo. Attendees will gain fresh perspectives on how stromal cells influence immunity and biological function across tissues and diseases, with built-in opportunities for networking and career development. 

The program will also spotlight emerging therapeutic targets and the rapid rise of stromal-directed therapies in the clinic. By uniting researchers across academic, clinical, and industry sectors with diverse expertise, this meeting will break down silos to foster cross-disciplinary collaborations and accelerate translational impacts. 

This conference will be held jointly with the Keystone Symposia on “Fibrosis: Cross Organ Pathology and Pathways to Clinical Development” to promote cross-fertilization of ideas and drive interdisciplinary collaborations and discoveries. This is an outstanding and synergistic pairing as fibroblast biology and function is closely intertwined with matrix biology, inflammation and immunity, that together contribute to overall tissue organization and the pathological manifestation of fibrosis.

In the video below, Dr. Anne Fletcher from Monash University, talks about what to expect from this meeting:

Also join Keynote Speaker, Dr. Thomas A. Wynn from Pfizer, as he adds is take on why to attend this meeting:

Additionally, check out the speaker highlights in the video below: